Aura Biosciences
在场
高管
查看带有其 22 名主要高管的组织结构图
Aura Biosciences 搜索最多的简介
- Elisabeth Pinos, Chief Executive Officer and Director
- David Johnson, Chairman of The Board
- Giovanni Mariggi, Director
高管在Aura Biosciences变化
- Mark Plavsic已作为Chief Technology Officer加入公司 (新闻发布的2023十月3号).
- Jill Hopkins已作为Chief Medical Officer and President of Research & Development加入公司 (新闻发布的2023十月3号).
创建提醒
跟踪 Aura Biosciences 的高管变动
生物技术
Aura Biosciences 拥有 2,281 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Aura Biosciences 的最新新闻稿
- Press Releases - Aura Biosciences
- Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights - Aura Biosciences
- Aura Biosciences to Participate in Upcoming Investor Conferences - Aura Biosciences
- Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board | Aura Biosciences
- Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors | Aura Biosciences
- Aura Biosciences Presents New Preclinical AU-011 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting | Aura Biosciences
- Aura Biosciences Announces Publication of Data in Cancer Immunology Research Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform | Aura Biosciences
- Aura Biosciences Expands Executive Leadership Team with the Appointment of Mark De Rosch, Ph.D., as Chief Operating Officer | Aura Biosciences
- Aura Biosciences Announces Oversubscribed $80 Million Financing | Aura Biosciences
- Aura Biosciences Appoints David Johnson to Its Board of Directors | Aura Biosciences
- View more press releases Close
通过电子邮件
